Shots:
The US FDA has approved Orlynvah (sulopenem etzadroxil & probenecid) to treat uUTIs in adult women, specifically addressing infections caused by E.coli, Klebsiella pneumoniae, or Proteus mirabilis, particularly when there are few or no other oral therapy available
Approval was based on two pivotal P-III studies (SURE 1 & REASSURE) that assessed the safety…
